Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II TrialPhilippe Armand, Leo I. Gordon, John M. Timmerman et al.|Journal of Clinical Oncology|2013Cited by 439
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHDBenjamin Watkins, Leslie S. Kean, Muna Qayed et al.|Journal of Clinical Oncology|2021Cited by 247
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxisMahasweta Gooptu, Mary Eapen, Rizwan Romee et al.|Blood|2021Cited by 163
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamideShannon R. McCurdy, Mary Eapen, Mei-Jie Zhang et al.|Blood Advances|2018Cited by 96
Circulating Progenitor Cells Identify Peripheral Arterial Disease in Patients With Coronary Artery DiseaseSalim S. Hayek, Arshed A. Quyyumi, James P. MacNamara et al.|Circulation Research|2016Cited by 49